Table 1.
Cohort | Tweet, 201712, a | Saw, 20175 | Lettieri, 20156, b | Rogowski, 20177 | Nakashima, 20168 |
---|---|---|---|---|---|
No. of patients | 323 | 327 | 134 | 64 | 63 |
Mean age, y | 45 ± 9.6 | 52.5 ± 9.6 | 52 ± 11 | 53 ± 11.2 | 46 ± 10 |
Female sex | 100 | 91 | 81 | 94 | 94 |
White race | 95 | 82 | — | — | — |
BMI, kg/m2 | 24.9 ± 5 | 24.4 (21.5–28.3) | 24.3 ± 3.5 | 24.8 ± 4.8 | 22.4 ± 4.2 |
DM | 0.9 | 4.6 | 2 | 0 | 0 |
Dyslipidemia | 35 | 26 | 33 | 52 | 23 |
HTN | 27 | 36 | 51 | 45 | 33 |
Current smoker | 0.6 | 10 | 34 | 28 | 32 |
Pregnancy associated | 17 | 2 | — | 5 | 8 |
History of infertility therapy | 18 | — | — | — | — |
History of hormonal birth control | 86 | — | — | — | 0 |
History of postmenopausal HT | 15 | 12 | — | — | 2 |
Migraines | 30 | 36 | — | — | — |
History of depression | 31 | 23 | — | — | — |
History of anxiety | 31 | 13.5 | — | 2c | — |
Extreme emotion/stress | 13 | 48 | — | — | 29 |
Extreme exertion | 12 | 28 | — | 19 | 10 |
FMD | 30d | 63 | — | 8e | 8f |
EVA | 36d | — | — | — | — |
Connective‐tissue disease | 2 | 5 | — | — | 2 |
STEMI | 40 | 26 | 49 | 30 | 87 |
NSTEMI | 58 | 74 | 40 | 69 | 13 |
CV arrest | 10 | VT/VF 9 | 2.8 | —g | Shock/arrest 16 |
Artery involvementf | |||||
LM | 8 | 0.6 | 2.8 | 3 | 0 |
LAD | 62 | 54 | 36 | 48 | 59 |
LCx | 15 | 38 | 15 | 16 | 6 |
RCA | 14 | 27 | 27 | 9 | 24 |
Ramus/OM/PDA/PLA | 22 | — | 19 | 31 | — |
Multivessel | 18 | 14 | 13 | 9 | 11 |
PCI | 45 | 17 | 38 | 11 | 54 |
PCI lack of success | 23 | 31 | 28 | 14 | 9 |
CABG | 10 | 2.1 | 6 | 1.6 | 1.6 |
In‐hospital death | 0 | 0 | 2.2 | 1.6 | — |
In‐hospital urgent revascularization | 2 | 4.3 | 1.5 | 0 | — |
Follow‐up | |||||
Median F/U time | 2.34 y (1.04–5.06 y) | 3.1 y (1.49–5.49 y) | 22 months (1–166 months) | 4.5 y (1.8–8.4 y) | 34 months (3–160 months) |
F/U MI | 18%; 21% 5‐y KM | 16.8%; 4.8%/y | 2 (1.6%) | 4 (6.3%)g | 18 (28.6%) |
F/U SCAD | 16%; 20% 5‐y KM | 10.4%; 2.8%/y | 4.7% | 3 (4.7%) | 22%; 27% 5‐y KM |
F/U HF | 2%; 3% 5‐yr KM | — | 5 (3.9%) | 0 | — |
F/U death | 0 | 0.3%/y | 4 (3.1%) | 0b | 1 (1.6%) |
Abbreviations: CABG, coronary artery bypass grafting; CV, cardiovascular; EVA, extracoronary vascular abnormalities; FMD, fibromuscular dysplasia; F/U, follow‐up; HF, heart failure; HT, hormone therapy; HTN, hypertension; IQR, interquartile range; KM, Kaplan–Meier; LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; LM, left main coronary artery; MI, myocardial infarction; NSTEMI, non–ST‐segment elevation myocardial infarction; OM, obtuse marginal artery; PCI, percutaneous coronary intervention; PDA, posterior descending artery; PLA, posterolateral artery; SCAD, spontaneous coronary artery dissection; SD, standard deviation; STEMI, ST‐segment elevation myocardial infarction; VF, ventricular fibrillation; VT, ventricular tachycardia.
Data are presented as %, mean ± SD, or median (IQR), unless otherwise noted.
Due to this study's focus on pregnancy‐associated SCAD, all patients included in this cohort were women.
11.9% of the patients in this cohort had atherosclerosis.
Documented as panic disorder.
If calculating percentages based on those imaged systematically for arteriopathies (n = 161), the percentage of FMD is 61% and EVA is 72%. EVA includes FMD but also noncoronary dilations, tortuosity, and dissection, as described elsewhere.21
Five patients of the 40 imaged had FMD (13%).
Five patients of the 24 imaged had FMD (21%).
One patient had in‐hospital cardiac arrest.
Denominators of the coronary artery percentages are total number of patients.
One patient with persistent SCAD had out‐of‐hospital cardiac arrest 16 days after initial diagnosis but was successfully resuscitated.